resources

The stock has been placed in Additional Surveillance Measure (ASM) list LTASM - I (13).

Evervie Health Ltd.

NSE: PVP

BSE: 517556

Sector: Realty

Industry Group: Realty

Industry: Residential, Commercial Projects

49.00-0.1 (-0.10%)

14 Oct, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Evervie Health Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	—	—	—	—	—	Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Jun
Conference Calls	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Presentations	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Corporate Announcements and Regulatory Filings

Evervie Health Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

General13 Oct 2026
Reporting As Per Paragraph 9.1 (A) Of The Aforesaid Chapter VIII Of SEBI Master Circular No. SEBI/HO/DDHS/DDHS - Pod/P/CIR/2025/0000000137 Dated October 15, 2025.
Reporting as per Paragraph 9.1 (a) of the aforesaid Chapter VIII of SEBI Master Circular No. SEBI/HO/DDHS/DDHS -PoD/P/CIR/2025/0000000137 dated October 15, 2025
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20189 Oct 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg 74(5) of SEBI(DP) Regulations,2018 for the Quarter ended 30th September, 2026
General8 Oct 2026
Advance Payment Of Interest Of Rs. 13.46 Crores, On Non-Convertible Debentures - Intimation Under Regulation 57 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Regulation 57 of the SEBI (LODR) Regulations, 2015 Company hereby confirms that the interest payable on its Non Convertible Debentures for the scheduled payment dates 31st December, 2026 ....
Reg. 34 (1) Annual Report6 Oct 2026
Reg. 34 (1) Annual Report.
Submission of Updated Annual Report for the Financial Year 2025-26 pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2
Change of Name5 Oct 2026
Announcement under Regulation 30 (LODR)-Change of Company Name
Pursuant to Regulation 30, Regulation 51 and other applicable provisions of the SEBI (Listing Obligations and Disclosure requirements) Regulations, 2015, we wish to inform you that the ....
General5 Oct 2026
Intimation Under Regulation 57 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Payment Of Interest
Pursuant to Regulation 57 of the SEBI ( Listing Obligations and Disclosure requirements) Regulations, 2015, we hereby confirm that the company has made the payment towards the Interest ....
General1 Oct 2026
Disclosure Under Regulation 30 Read With Clause 7C Of Para A Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Resignation Of Dr. Ellen Jane Feehan And Dr. Neeraja Nagarajan
Pursuant to regulation 30 read with clause 7C Para A of Schedule III of SEBI (LODR) Regulations 2015, the respective communications received from the Dr. Ellen Jane Feehan and Dr. Neeraja ....
Closure of Trading Window29 Sept 2026
Closure of Trading Window
Trading window for the dealing in securities for all the designated Persons and their immediate relatives and insiders will remain close w.e.f 01.10.2026 till 48 hours after declaration ....
Resignation of Director24 Sept 2026
Announcement under Regulation 30 (LODR)-Resignation of Director
Dr. Neeraja Nagarajan, tendered her resignation from the position as Executive Director and COO of the Company citing her personal reasons
Resignation of Director24 Sept 2026
Announcement under Regulation 30 (LODR)-Resignation of Director
Ms. Ellen Jane Feehan, Executive Director & CEO of the Company has tendered her resignation from her position, citing her unavoidable Personal Health reasons
Resignation of Chief Executive Officer (CEO)24 Sept 2026
Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)
Dr. Ellen Jane Feehan, Executive Director & CEO of the Company has tendered her resignation to her position, citing unavoidable personal health reasons on 24th September 2026.
General17 Sept 2026
Intimation Of Record Date Pursuant To Regulation 60(2) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
Record Date : 23.09.2026 for the purpose of interest payment in respect of the Non - Convertible Debentures (NCDS)
Record Date17 Sept 2026
Intimation Of Record Date Pursuant To Regulation 60(2) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015
Record date: 23.09.2026 For the purpose of interest payment in respect of the Non- Convertible Debentures (NCDS) issued by the Company
AGM7 Sept 2026
Report Of The Scrutinizer
Report of the Scrutinizer
AGM7 Sept 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 35th Annual general Meeting of the company held on 07th September, 2026 at 10.00 AM
General7 Sept 2026
Announcement Of Resignation Of Company Secretary And Compliance Officer Of The Company Under Schedule III, Part A, 7C Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Resignation of Mr. B Vignesh Ram as the company secretary and compliance officer of the company
Resignation of Company Secretary / Compliance Officer7 Sept 2026
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Resignation of Mr. B Vignesh Ram as the company Secretary and compliance officer of the company with effect from 11th September,2026
Appointment of Company Secretary / Compliance Officer7 Sept 2026
Appointment of Company Secretary and Compliance Officer
Appointment of Mr. Vinay Paruchuru as the Company Secretary and Compliance Officer with effect from 14th September, 2026
Outcome without intimation7 Sept 2026
Board Meeting Outcome for Outcome Of Board Meeting For Appointment & Resignation Of Company Secretary And Compliance Officer
Outcome of Board Meeting for Appointment & Resignation of Company Secretary and Compliance Officer
Newspaper Publication4 Sept 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication

Frequently Asked Questions

Where can I download the annual report of Evervie Health Ltd.?

Annual reports of Evervie Health Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Evervie Health Ltd.?

Quarterly earnings results and presentations of Evervie Health Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Evervie Health Ltd. publish earnings call transcripts?

Earnings call transcripts of Evervie Health Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Evervie Health Ltd.?

Investor presentations and annual day presentations of Evervie Health Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Evervie Health Ltd.?

Corporate announcements and regulatory filings of Evervie Health Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Evervie Health Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Evervie Health Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Evervie Health Ltd.?

The ISIN (International Securities Identification Number) of Evervie Health Ltd. is INE362A01016. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Evervie Health Ltd. listed?

Evervie Health Ltd. is listed on NSE and BSE. The NSE symbol is PVP and the BSE code is -.

Where can I find the shareholding pattern of Evervie Health Ltd.?

The quarterly shareholding pattern of Evervie Health Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Evervie Health Ltd. on Sharpely?

Share price data for Evervie Health Ltd. is updated as of 14 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.